(Entocord™, Entocir™, Budecol™, Zentacort™)
Indications:
Entocort™ (budesonide) is a glucocorticosteroid with a high local anti-inflammatory effect.
Entocort™ capsule is indicated for:
- Crohn’s disease – Induction and maintenance of remission in patients with mild to moderate episodes of Crohn’s disease involving the ileum and/or the ascending colon.
- Microscopic colitis – Induction of remission in patients with active microscopic colitis.
Entocort™ ENEMA is indicated for the treatment of ulcerative colitis involving the rectum, the sigmoid and the descending colon.
Formulations:
Capsule and ENEMA.
Last update: December 2024.
This medicine is only available upon prescription. The diseases or conditions for the treatment of which this product has been approved by the regulatory authority may not be the same in all countries. This product may not be available in the country where you practice medicine or reside because its supply has not been approved by the local regulatory authority. Healthcare professionals should consult the relevant officially approved prescriber’s information before prescribing or making this product available to patients. Patients and their caregivers should use this product in accordance with the advice of a healthcare professional and the patient information officially approved in their country of residence.